πŸ‡ΊπŸ‡Έ FDA
Patent

US 9163248

Targeting pseudotyped retroviral vectors

granted A61KA61K2039/5256A61K39/395

Quick answer

US patent 9163248 (Targeting pseudotyped retroviral vectors) held by The Regents of the University of California expires Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 20 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 15 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61K, A61K2039/5256, A61K39/395, A61K39/39558, A61K48/00